Most people taking Olumiant (baricitinib) for alopecia areata need at least six months before they can tell whether the medication is working. Some notice early fuzz within a few weeks, but meaningful hair coverage typically takes 36 weeks or longer to appear. Full regrowth can take anywhere from 6 to 18 months depending on the person.
What to Expect in the First Few Months
The earliest sign of progress is usually fine, soft regrowth that some people describe as peach fuzz. This can show up within a few weeks of starting treatment, but it’s not a reliable indicator of how well the medication will ultimately work. Experts at the National Alopecia Areata Foundation are clear on this point: neither you nor your doctor can meaningfully judge whether Olumiant is working until you’ve been on it for at least six months.
That waiting period can feel long, especially when you’re checking the mirror daily. But hair follicles that have been dormant under immune attack don’t switch back on overnight. Olumiant works by blocking specific immune signaling pathways (JAK1 and JAK2) that drive the inflammation responsible for alopecia areata. Once that immune attack quiets down, follicles still need time to re-enter their growth cycle and produce visible hair.
Results at 36 Weeks
The clearest picture of Olumiant’s timeline comes from two large clinical trials involving 1,200 adults with severe alopecia areata. At the 36-week mark (roughly 8 to 9 months), results depended heavily on dose:
- 4 mg daily: About 36 to 39% of patients achieved 80% or more scalp hair coverage. Roughly 24 to 26% reached 90% or more coverage.
- 2 mg daily: About 19 to 23% of patients achieved 80% or more scalp hair coverage.
- Placebo: Only about 4% saw similar improvement.
These numbers kept climbing after 36 weeks. By week 52 (one year), 39% of patients on the higher dose and nearly 23% on the lower dose had achieved at least 80% scalp coverage. So if you’re seeing some improvement at the six-month mark but aren’t where you’d like to be, continued treatment often yields more regrowth over the following months.
Factors That Affect Your Timeline
Not everyone responds at the same speed, and some people don’t respond at all. A long-term real-world study identified two factors that significantly predicted a better response: being female and having had alopecia areata for less than four years. If your current episode has lasted longer than four years, regrowth may take longer or be less complete, though some people with longstanding disease still see meaningful improvement.
Dose also matters. The 4 mg daily dose consistently outperformed the 2 mg dose across trials, producing roughly double the response rate at every time point measured. Your prescriber will weigh the higher efficacy of 4 mg against your individual risk profile when choosing a dose.
Eyebrows, Eyelashes, and Body Hair
Clinical trial data focused primarily on scalp hair, and specific timelines for eyebrow and eyelash regrowth are less well documented. The general pattern follows the same arc: early fuzz may appear within weeks, but substantial regrowth takes six months or more. Some people find that facial hair lags behind scalp hair, while others see it return around the same time. If your eyebrows or eyelashes haven’t budged by six months, that doesn’t necessarily mean they won’t, as full regrowth for some patients takes 12 to 18 months.
What Happens If You Stop Taking It
Olumiant controls the immune dysfunction behind alopecia areata rather than curing it, which means stopping the medication typically leads to hair loss returning. In a study that tracked patients after they discontinued treatment, the timeline looked like this: no one had lost their regrowth at four weeks off the drug, and only 10 to 11% had lost it by eight weeks. But by week 152 (about three years after stopping), 80% of patients in both dose groups had lost their treatment benefit. Among those who stayed on the medication, only 7% lost their hair.
The practical takeaway is that most people need to keep taking Olumiant to maintain their results. Current expert consensus recommends considering discontinuation only after you’ve achieved complete regrowth and maintained it for at least six months, or when remaining hair loss is mild enough to manage with topical treatments. If you do stop and lose hair, restarting the medication can recapture previous results for many patients.
Monitoring During Treatment
Because Olumiant affects your immune system, your doctor will run blood tests before you start and periodically during treatment. These typically include a complete blood count, liver and kidney function tests, and a lipid panel around 12 weeks after starting. The goal is to catch any changes in blood cell counts, liver enzymes, or cholesterol early so your dose can be adjusted if needed. Most of these checks are straightforward lab draws and become less frequent once your levels are stable.
Setting Realistic Expectations
The hardest part of Olumiant treatment for many people is the wait. Committing to a daily medication for six months before you can even evaluate whether it’s working requires patience, and the reality that roughly 60% of patients on the higher dose don’t achieve 80% scalp coverage at 36 weeks means it doesn’t work for everyone. That said, response rates continue to improve beyond 36 weeks, and some people who show only modest early progress go on to achieve significant regrowth by 12 to 18 months.
If you’re in the early months of treatment and feeling discouraged by slow progress, the clinical data supports giving it time. The six-month evaluation window exists because hair regrowth from alopecia areata is genuinely slow, not because the drug takes that long to start working at a cellular level. The immune suppression begins quickly, but the visible results follow on the hair follicle’s own schedule.